Enbridge (ENB) and Chevron (CVX) stand out as two of the most compelling high-yield picks in today’s market, offering compelling combinations of yield and dividend reliability. Enbridge delivers a 5.4% dividend yield backed by 31 consecutive years of dividend increases, while Chevron provides a 3.89% forward yield with an impressive 38 years of consecutive dividend growth. Meanwhile, AbbVie (ABBV) serves as a cautionary tale—despite being a Dividend King with 53 consecutive years of dividend increases, it has declined 9.82% year-to-date, demonstrating that a fortress dividend history alone cannot protect an investor from price deterioration.
The current market environment presents both opportunity and risk for income-focused investors. High-yield stocks are appealing to those seeking steady cash flow, but not all dividend payers are created equal. The three stocks examined here represent different scenarios: two that have managed to grow income streams while maintaining stable valuations, and one where the income promise has masked underlying business challenges. Understanding the distinctions between them is essential for building a resilient income portfolio.
Table of Contents
- What Makes High-Yield Stocks Attractive in 2026?
- The Compelling Case for Enbridge and Chevron
- Why AbbVie’s Dividend King Status Doesn’t Guarantee Returns
- Comparing Yields Across the Broader High-Yield Landscape
- Dividend Sustainability and Payout Ratio Risks
- The Role of Duration and Tax Efficiency
- How to Screen and Evaluate High-Yield Candidates
What Makes High-Yield Stocks Attractive in 2026?
High-yield dividend stocks have become increasingly popular as interest rates stabilize and investors seek alternatives to bonds. A stock yielding 5.4% like Enbridge offers meaningful income relative to money market accounts, which typically pay 4% to 4.5% in 2026. The appeal is straightforward: dividend stocks provide recurring income while offering the potential for capital appreciation, a dual-return opportunity that bonds cannot match. The consistency of dividend payments matters as much as the yield itself.
A stock paying 5% but cutting its dividend frequently creates risk and uncertainty, whereas a company that has raised its dividend for three decades signals management confidence and financial discipline. Enbridge’s 31-year dividend growth streak reflects its ability to operate profitably through multiple economic cycles, a track record that carries real weight when evaluating whether a yield is sustainable or a trap. High-yield stocks also serve a structural purpose in portfolios—they typically correlate differently with growth equities and can reduce overall portfolio volatility. However, yield-chasing without fundamental analysis remains one of the most common investor mistakes. A stock yielding 13% when the broader market yields 3% often signals that the market has priced in significant risk, from regulatory threats to declining cash flows.
The Compelling Case for Enbridge and Chevron
Enbridge operates 18,000 miles of crude oil pipelines and 19,000 miles of natural gas pipelines, making it a critical piece of North American energy infrastructure. This isn’t a discretionary business—oil and natural gas still power the continent’s economy and heating systems regardless of market sentiment. Pipelines generate cash from long-term contracts that are largely insulated from commodity price fluctuations, which provides visibility that pure oil and gas exploration companies cannot match. The 5.4% yield, combined with three decades of annual dividend increases, reflects cash generation that has proven resilient even during energy downturns. Chevron’s 38-year dividend growth record is similarly impressive and speaks to a company that has managed capital effectively through commodity cycles.
Its 3.89% forward yield is lower than Enbridge’s, but the stability and risk-reward profile make it an alternative for investors who want lower volatility exposure to energy. Chevron has fared better than smaller oil peers during downturns because of its scale and integrated operations spanning exploration, refining, and marketing. The limitation of both stocks lies in the broader energy transition. While Enbridge and Chevron are not going obsolete in the next decade, investors should acknowledge that the long-term demand trajectory for crude oil and natural gas is uncertain. Enbridge’s dividend is safer than Chevron’s because pipeline contracts are more predictable, but neither company is immune to regulatory or demand pressures. A prudent investor treats these as cyclical income plays, not eternal cash cows.
Why AbbVie’s Dividend King Status Doesn’t Guarantee Returns
AbbVie holds the title of Dividend King with 53 consecutive years of dividend increases—longer than almost any other public company. This remarkable streak is historically significant and demonstrates deep management commitment to shareholders. Yet the stock’s 9.82% year-to-date decline reveals an uncomfortable truth: dividend growth does not guarantee that shareholders will make money overall. AbbVie’s principal business is pharmaceuticals, an industry facing headwinds from Ozempic’s disruption (impacting its obesity and diabetes positioning), generic competition, and pricing pressures from Medicare negotiation. The danger with AbbVie is that markets have been repricing the company as the pipeline and blockbuster prospects have disappointed.
The dividend remains safe for now—the company still generates sufficient cash—but the stock price weakness suggests the market has low conviction about future growth. An investor who bought AbbVie solely for its dividend streak and held without reassessing the underlying business would have lost roughly 10% of capital while collecting the income yield, a poor total return. This illustrates a critical distinction: a long dividend-growth record is valuable because it reflects management discipline, but it is not a guarantee of future performance. AbbVie’s underperformance should prompt investors to ask whether the dividend can continue growing, and whether the stock will stabilize or face further repricing. A fortress dividend sometimes masks deteriorating competitive position.
Comparing Yields Across the Broader High-Yield Landscape
The market offers high-yield opportunities beyond energy and pharmaceuticals. According to research from July 2026, stocks including PepsiCo, BB Seguridade, Novo Nordisk, and Rio Tinto feature yields exceeding 13% in select cases, often combined with undervaluation. These extreme yields warrant skepticism—they sometimes indicate distressed situations or cyclical lows where mean reversion is uncertain. Comparing Enbridge’s 5.4% yield to stocks offering 13% highlights a key trade-off: higher yields often come with higher risk or higher expectations for capital appreciation. Rio Tinto, for example, is a commodities business whose dividend can swing dramatically based on commodity prices.
A 13% yield from Rio Tinto is attractive on paper but carries the risk that next year’s dividend is cut by 30-50% if prices decline. Enbridge, by contrast, is more stable and offers lower yield precisely because investors have confidence in dividend continuity. The comparison is not yield versus yield, but certainty versus speculation. Investors should use yield as a screening tool, not an investment thesis. The proper approach is to identify companies paying sustainable yields (4-6% is typical for quality blue-chip dividend stocks) and then drill into the fundamentals—cash flow, debt levels, dividend payout ratios, and industry headwinds. Yielding 5.4% means nothing if the yield is unsustainable.
Dividend Sustainability and Payout Ratio Risks
One of the most overlooked metrics is the dividend payout ratio—the percentage of earnings paid out as dividends. If a company earns $2 per share and pays $1 in dividends, the payout ratio is 50%, leaving room for growth and a margin of safety. A payout ratio above 80-90% leaves little cushion if earnings decline. Companies approaching payout limits may cut dividends not out of distress but out of necessity to retain earnings for debt or reinvestment. AbbVie’s situation exemplifies this risk.
A high-yield stock facing headwinds in its core business may be forced to reduce the dividend, especially if earnings are declining. The market sometimes prices in dividend cuts before they are announced, explaining AbbVie’s weakness. Enbridge’s lower growth rate in earnings is partially offset by the resilience of its cash flows—a pipeline business does not experience the earnings volatility of a pharmaceutical maker. The practical warning: never buy a high-yield stock assuming the yield is permanent. Evaluate the company’s ability to maintain and grow its dividend through a business downturn. Enbridge passes this test; Chevron mostly does; AbbVie does not, given current business challenges.
The Role of Duration and Tax Efficiency
High-yield stocks suit longer holding periods where compounding of dividends can occur. An investor buying Enbridge at 5.4% yield and reinvesting dividends for 10 years benefits from both the original dividend and the growth of the dividend over time. If Enbridge raises its dividend by 4-5% annually (consistent with historical patterns), the yield on the original cost will grow substantially, a power that current-yield statistics do not capture.
Tax efficiency is a secondary but meaningful consideration. Dividend income is taxed as ordinary income for most investors, unlike capital gains. High-dividend portfolios can be tax-inefficient in taxable accounts, suggesting that high-yield stocks may work better in retirement accounts (IRAs, 401k plans) where dividend taxes are deferred or eliminated. For taxable accounts, the same 5.4% yield might be more efficient in a broad index fund where gains are realized less frequently.
How to Screen and Evaluate High-Yield Candidates
The process of identifying reliable high-yield stocks begins with yield relative to historical norm. A stock that usually yields 3% but now yields 6% suggests either a temporary price decline (opportunity) or a deteriorating business (trap). Historical context matters. Enbridge’s 5.4% yield is above its 5-year average but not so extreme as to suggest distress; it reflects a quality company trading at reasonable valuation. Next, examine the dividend track record. Companies with 30+ years of consecutive increases have withstood recessions, wars, oil crises, and financial crashes—a proven test of resilience.
Chevron’s 38-year streak is particularly significant given the volatility of the energy sector. By contrast, a company with 5 years of growth is untested and could cut the dividend in the next downturn. AbbVie’s 53-year streak is a historical achievement but offers no protection if the business fundamentals shift rapidly, as they have in recent years due to Ozempic competition. The practical step is to review the most recent earnings report and balance sheet. Does the company have manageable debt? Is cash flow from operations positive and stable? Are earnings declining, flat, or growing? Enbridge’s predictable cash flows from long-term contracts make it easier to project dividend sustainability than Chevron’s more volatile earnings. For AbbVie, the recent earnings trajectory has been concerning, which should prompt caution regardless of the dividend history.